Comment on "Efficacy of Chinese Medicine on Postoperative Rehabilitation of Non-Small Cell Lung Cancer (NSCLC), a Randomized Controlled Study".
0/5 보강
APA
Zhou X, Chen J, et al. (2026). Comment on "Efficacy of Chinese Medicine on Postoperative Rehabilitation of Non-Small Cell Lung Cancer (NSCLC), a Randomized Controlled Study".. Integrative cancer therapies, 25, 15347354261420552. https://doi.org/10.1177/15347354261420552
MLA
Zhou X, et al.. "Comment on "Efficacy of Chinese Medicine on Postoperative Rehabilitation of Non-Small Cell Lung Cancer (NSCLC), a Randomized Controlled Study".." Integrative cancer therapies, vol. 25, 2026, pp. 15347354261420552.
PMID
41641792
같은 제1저자의 인용 많은 논문 (5)
- Integrative multi-omics and machine learning framework identifies PRDX4 as a redox-EMT regulator and predictive marker in bone-metastatic breast cancer.
- Nintedanib combined with anticoagulant therapy in advanced lung cancer complicated with pulmonary fibrosis and pulmonary embolism: two case reports and clinical decision-making analysis.
- Identification and validation of a refined CAF-Associated diagnostic signature in breast cancer.
- Macrophage ferroptosis in hematologic malignancies: emerging mechanisms and therapeutic implications.
- Diabetogenic processes for insulin resistance-linked hyperinsulinaemia are associated with colorectal cancer.